<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="886">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05149625</url>
  </required_header>
  <id_info>
    <org_study_id>H-2109-138-1257</org_study_id>
    <nct_id>NCT05149625</nct_id>
  </id_info>
  <brief_title>Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy</brief_title>
  <official_title>Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy : A Randomized Controlled Open Labeled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the efficacy and satisfaction of blood glucose management between&#xD;
      continuous glucose monitoring versus traditional self blood glucose measurement in diabetic&#xD;
      patients after pancreatectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be enrolled after the 75g oral glucose tolerance test performed 7 days after&#xD;
      pancreatectomy. Patients will be divided into two groups by randomization (continuous glucose&#xD;
      measurement method vs. traditional self blood glucose measurement method), and 3months after&#xD;
      surgery, HbA1c, hypoglycemic events, and satisfaction would be compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 15, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin A1c (HbA1c)</measure>
    <time_frame>postoperative 3months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hypoglycemic events</measure>
    <time_frame>postoperative 3months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>satisfaction survey</measure>
    <time_frame>postoperative 3months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting, postprandial plasma glucose</measure>
    <time_frame>postoperative 3months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">172</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Dexcom G6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional self-blood glucose measurement</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dexcom G6</intervention_name>
    <description>continuous glucose monitoring device</description>
    <arm_group_label>Dexcom G6</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 19 years of age&#xD;
&#xD;
          -  Preoperative diabetes history&#xD;
&#xD;
          -  Patients who underwent subtotal or total pancreatectomy&#xD;
&#xD;
          -  Patients who were diagnosed with diabetes mellitus in the evaluation of endocrine&#xD;
             function test on the 7th day after pancreaticoduodenectomy, central pancreatectomy, or&#xD;
             distal pancreatectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who have used continuous blood glucose measurement device more than once&#xD;
             before.&#xD;
&#xD;
          -  Elderly patients who are not accustomed to using the smartphone applications&#xD;
&#xD;
          -  Serious systemic diseases that can affect diabetes (chronic kidney disease, heart&#xD;
             failure, decompensated liver cirrhosis, etc.)&#xD;
&#xD;
          -  Steroid user during the study period&#xD;
&#xD;
          -  Major medical or psychiatric condition that will affect response to treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Young Jang, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jin-Young Jang, Dr</last_name>
    <phone>+82-02-2072-2194</phone>
    <email>jangjy4@gmail.com</email>
  </overall_contact>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 26, 2021</study_first_submitted>
  <study_first_submitted_qc>November 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2021</study_first_posted>
  <last_update_submitted>November 26, 2021</last_update_submitted>
  <last_update_submitted_qc>November 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Young Jang</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

